Sexually transmitted infections in adolescent women

Clinical Obstetrics and Gynecology

Volumn 51, Issue 2, 2008, Pages 306-318

  Tarr, Megan E ^a   Gilliam, Melissa L ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

Adolescents; Chlamydia trachomatis; Neisseria gonorrhea; Pelvic inflammatory disease; Teens

Indexed keywords

AMOXICILLIN; AZITHROMYCIN; CEFIXIME; CEFOTAXIME; CEFOTETAN; CEFOXITIN; CEFPODOXIME; CEFTIZOXIME; CEFTRIAXONE; CEFUROXIME AXETIL; CEPHALOSPORIN; CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; ERYTHROMYCIN ETHYLSUCCINATE; GENTAMICIN; LEVOFLOXACIN; MACROLIDE; METRONIDAZOLE; OFLOXACIN; PROBENECID; QUINOLINE DERIVED ANTIINFECTIVE AGENT; SPECTINOMYCIN; SULTAMICILLIN;

BACTERIAL INFECTION; BEHAVIOR; CHLAMYDIA; CHLAMYDIASIS; CLINICAL FEATURE; CLINICAL TRIAL; COMMUNITY; CONFIDENTIALITY; COUNSELING; FEMALE FERTILITY; FOLLOW UP; GONOCOCCAL URETHRITIS; GONORRHEA; HUMAN; KNOWLEDGE; PATHOPHYSIOLOGY; PELVIC INFLAMMATORY DISEASE; PHYSIOLOGY; RECTAL INFECTION; REVIEW; RISK; SCREENING; SEXUALLY TRANSMITTED DISEASE; SYMPTOM; TUBOOVARIAN ABSCESS; UTERINE CERVICITIS;

ADOLESCENT; ADOLESCENT PSYCHOLOGY; CHLAMYDIA INFECTIONS; CONDOMS; COUNSELING; FEMALE; GONORRHEA; HUMANS; MASS SCREENING; PELVIC INFLAMMATORY DISEASE; RISK-TAKING; SEXUAL BEHAVIOR; SEXUALLY TRANSMITTED DISEASES; TREATMENT OUTCOME;

EID: 43249097369     PISSN: 00099201     EISSN: None     Source Type: Journal    
DOI: 10.1097/GRF.0b013e31816d7386     Document Type: Review

References (23)

1. American College of Obstetricians and Gynecologists. Health care for adolescents: screening for chlamydia and gonorrhea in adolescents. 2003 [cited August 13, 2007]. Available at: http://www.acog.org/publications/adolescents/ adol07.cfm?.
2. Datta SD, Sternberg M, Johnson RE, et al. Gonorrhea and chlamydia in the United States among persons 14 to 39 years of age, 1999 to 2002. Ann Intern Med. 2007;147:89-96.
3. Workowski KA, Berman SM. Sexually transmitted diseases treatment guidelines, 2006. MMWR Recomm Rep. 2006;55:1-94.
4. ACOG Committee Opinion #301. Sexually transmitted diseases in adolescents. Obstet Gynecol. 2004;104:891-898.
5. Preventive Services Task Force recommendation statement. Screening for chlamydial infection. Ann Intern Med. 2007;147:128-134.
6. Gray-Swain MR, Peipert JF. Pelvic inflammatory disease in adolescents. Curr Opin Obstet Gynecol. 2006;18:503-510.
7. Shrier LA. Bacterial sexually transmitted infections: gonorrhea, chlamydia, pelvic inflammatory disease, and syphilis. In: Emans SJ, Laufer MR, Goldstein DP, eds. Pediatric and Adolescent Gynecology. 5th ed. Philadelphia: Lippincott, Williams and Wilkins; 2005:565-614.
8. Centers for Disease Control and Prevention. STD surveillance 2005, special focus profiles: adolescents and young adults. 2006 [cited August 14, 2007]. Available at: http://www.cdc.gov/std/stats/adol.htm.
9. Shih S, Scholle S, Irwin K, et al. Chlamydia screening among sexually active young female enrollees of health plans - United States, 1999-2001. MMWR. 2004;53:983-985.
10. Johnson RE, Newhall WJ, Papp JR, et al. Screening tests to detect Chlamydia trachomatis and Neisseria gonorrhoeae infections - 2002. MMWR Recomm Rep. 2002;51:1-38; quiz CE1-4.
11. Cook RL, Hutchison SL, Ostergaard L, et al. Systematic review: noninvasive testing for Chlamydia trachomatis and Neisseria gonorrhoeae. Ann Intern Med. 2005;142:914-925.
12. Spigarelli MG. Urine gonococcal/chlamydia testing in adolescents. Curr Opin Obstet Gynecol. 2006;18:498-502.
13. Centers for Disease Control and Prevention. Updated recommended treatment regimens for gonococcal infections and associated conditions-United States, April 2007 [cited April 21, 2007]. Available at: http://www.cdc.gov/std/ treatment/2006/updated-regimens.htm.
14. delRio C, Hall G, Hook EW, et al. Update to CDC's sexually transmitted diseases treatment guidelines, 2006: fluoroquinolones no longer recommended for treatment of gonococcal infections. MMWR. 2007;56:332-336.
15. Centers for Disease Control and Prevention. Tracking the Hidden Epidemics: Trends in STDs in the United States, 2000. Atlanta: CDC; 2000.
16. Scholes D, Stergachis A, Heidrich FE, et al. Prevention of pelvic inflammatory disease by screening for cervical chlamydial infection. N Engl J Med. 1996;334:1362-1366.
17. Mollen CJ, Pletcher JR, Bellah RD, et al. Prevalence of tubo-ovarian abscess in adolescents diagnosed with pelvic inflammatory disease in a pediatric emergency department. Pediatr Emerg Care. 2006;22:621-625.
18. Ness RB, Soper DE, Holley RL, et al. Effectiveness of inpatient and outpatient treatment strategies for women with pelvic inflammatory disease: results from the Pelvic Inflammatory Disease Evaluation and Clinical Health (PEACH) Randomized Trial. Am J Obstet Gynecol. 2002;186:929-937.
19. Ness RB, Trautmann G, Richter HE, et al. Effectiveness of treatment strategies of some women with pelvic inflammatory disease: a randomized trial. Obstet Gynecol. 2005;106:573-580.
20. Savaris RF, Teixeira LM, Torres TG, et al. Comparing ceftriaxone plus azithromycin or doxycycline for pelvic inflammatory disease: a randomized controlled trial. Obstet Gynecol. 2007;110:53-60.
21. Shain RN, Piper JM, Holden AE, et al. Prevention of gonorrhea and chlamydia through behavioral intervention: results of a two-year controlled randomized trial in minority women. Sex Transm Dis. 2004;31:401-408.
22. Paz-Bailey G, Koumans EH, Sternberg M, et al. The effect of correct and consistent condom use on chlamydial and gonococcal infection among urban adolescents. Arch Pediatr Adolesc Med. 2005;159:536-542.
23. Middleton DB, Zimmerman RK, Mitchell KB.Vaccine schedules and procedures, 2007. J Fam Pract. 2007;56(2 suppl Vaccines): S47-S60, C4-C8.